Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
July 9, 2003
Conditions
Breast CancerOvarian Cancer
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00043472 - Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk | Biotech Hunter | Biotech Hunter